PHARMAERO ApS: Financial statements 2018
CVR: 32827942
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
PHARMAERO ApS (CVR 32827942) has filed annual accounts for 2018. In 2018, the company reported a net result of DKK -132,278,000 compared with DKK -1,450 the year before. Equity in the 2018 report amounted to DKK 6,747,000. The solvency ratio was 32.4%. The company had 1 employee in the financial year.
- Profit/Loss
- DKK -132,278,000
- Equity
- DKK 6,747,000
- Total Assets
- DKK 20,840,000
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | - | -132.3 mio. | 6.7 mio. | 1 |
| 2017 | 0 | 0 | -1 t. | 100 t. | 1 |
| 2016 | 1 t. | 1 t. | -660 t. | 87.8 mio. | - |
| 2015 | - | 0 | 168 t. | 65.4 mio. | - |
| 2014 | - | 0 | 507 t. | 55.2 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of November 5, 2018, Mikkel Lyager Olsen has joined the board of directors of PHARMAERO ApS.
As of November 5, 2018, Markus Puusepp has joined the board of directors of PHARMAERO ApS.
As of September 24, 2018, Mats Persson is registered as director of PHARMAERO ApS.
As of September 24, 2018, Pietro Crovetto has stepped down as director of PHARMAERO ApS.
PHARMAERO ApS has published its annual report for 2017. Revenue came to DKK 0, and the net result was DKK -1,450.
About PHARMAERO ApS
PHARMAERO ApS was a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2010. The company has been dissolved on 15 May 2025. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company has 1 employee (2019). In 2023, the company reported a gross profit of DKK -18,615 and a net result of DKK -20,072 compared with DKK -650,593 the year before. Equity in the 2023 report amounted to DKK 51,918.